Stockscreener 앱 받기
28.15
2.16%
-0.62
Hims Hers Health Inc 주식(HIMS)의 최신 뉴스
Hims & Hers Health (NYSE:HIMS) Upgraded to Hold at Wall Street Zen - MarketBeat
Hims & Hers Health, Inc. • Robinhood Token Price, HIMS Price, Live Charts, and Marketcap - Coinbase
Hims & Hers Health CTO Mohamed Elshenawy Awarded 1.2 Million RSUs - Kalkine Media
Hims & Hers Health Director Christopher D. Payne Awarded 8,768 RSUs in August 2026 - Kalkine Media
Citi Says Hims & Hers’ Full-Year Outlook Indicates ‘Hefty’ Q4 Earnings Lift, Warns Of Execution Risks - Stocktwits
Hims & Hers (HIMS) Raised Guidance. Can Growth Survive Its GLP-1 Margin Reset? - Yahoo Finance
Hims & Hers Health raises 2023 revenue outlook after strong Q2 growth despite margin drop - pluang.com
Hims & Hers Health's Next Act: Making Its Own Drugs Again (NYSE:HIMS) - Seeking Alpha
Kaplan Fox Reminds Investors of Hims & Hers Health, Inc. (NYSE: H - The National Law Review
Hims & Hers Health Inc (HIMS) Shares Fall 4.0% -- What GF Score of 78 Tells Investors - GuruFocus
Kaplan Fox is Investigating Hims & Hers Health, Inc. (NYSE: HIMS) for Potential Securities Law Violations - The National Law Review
HIMS Q2 Deep Dive: AI Strategy and International Expansion Shape Telehealth Outlook - Yahoo Finance
HIMS Investigation: Kessler Topaz Meltzer & Check, LLP - GlobeNewswire
Utah sues Hims over alleged 'subscription trap,' sharing of private health data - St. George News
Securities Fraud Investigation Into Hims & Hers Health, - GlobeNewswire
FTC lawsuit alleges Hims & Hers charged consumers for unwanted prescriptions - Top Class Actions
HIMS SHAREHOLDER ALERT: Hims & Hers Health, Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations - Business Wire
A Major Telehealth Company Will Sell Longevity Peptides That Clinical Evidence Has Not Yet Backed - Medical Daily
Hims & Hers upgrades women's health app with AI, smart scale integration - TechTarget
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Hims & Hers Health, Inc. (HIMS) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Hims & Hers shared patient health data with Meta, Snap and other advertisers, new class action lawsuit claims - claimdepot.com
NYSE: HIMS Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm - Morningstar
As Hims prepares for peptides launch, Wall Street cautious on prospects this year - Reuters
Investigation launched into Hims & Hers for all... - Pluang
Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS) - marketscreener.com
Hims & Hers’ Revenue Beat Came With a Profitability Problem - MarketBeat
Hims & Hers: The Guidance Raise Doesn't Fix The Margin Problem (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health (HIMS) Stock Looks Cheap Even With Legal Risk - Yahoo Finance
Hims & Hers Health, Inc. (HIMS) LawsuitInvestors Urged to Contact Levi & Korsinsky Before August 25, 2025 - The National Law Review
Hims & Hers Health: Algorithmic Transformation of Consumer Healthcare - healthcare.digital
Investor relations - HIMS investor relations
Hims & Hers Q2 Revenue Jumps 38% as International Expansion Accelerates - globalcosmeticsnews.com
HIMS Stock Snaps 2-Day Climb: Analyst Says Record Subscriber Growth ‘Not Enough’ To Offset Margin Slide - TradingView
Hims & Hers Health, Inc. Signals Aggressive Growth Path - TipRanks
Hims & Hers Health, Inc. (HIMS) Stock forecasts - Yahoo Finance Singapore
A Look at Hims & Hers Health Inc (HIMS) After 4.0% Decline -- GF Value $40.71 vs Price $30.51 - GuruFocus
Hims & Hers planning to sell compounded peptides - The Hill
Hims & Hers Health (NYSE:HIMS) Price Target Cut to $33.00 by Analysts at Citigroup - MarketBeat
FTC Continues Investigation into Hims & Hers Health, Inc. as Lowey Dannenberg Files Class ... - Caledonian Record
FTC Continues Investigation into Hims & Hers Health, Inc. - GlobeNewswire
HIMS Maintained by Morgan Stanley -- Price Target Raised to $28 - GuruFocus
HIMS Maintained by B of A Securities -- Price Target Raised to $32.00 - GuruFocus
HIMS Maintained by Deutsche Bank -- Price Target Raised to $26 - GuruFocus
HIMS Maintains Hold by TD Cowen -- Price Target Raised to $30 - GuruFocus
Bank of America Forecasts Strong Price Appreciation for Hims & Hers Health (NYSE:HIMS) Stock - MarketBeat
Hims & Hers Health, Inc. Stock 12‑Month Price Target Raised to $32.23, Implies 1% Upside - tradingview.com
Hims & Hers Stock Plunges Post Q2 Earnings Miss, Gross Margin Down - Yahoo Finance
Will Hims & Hers’ Higher 2026 Revenue Guidance Amid Rising Losses Change HIMS’s Investment Narrative? - finance.yahoo.com
Hims & Hers Health (NYSE:HIMS) Shares Gap DownTime to Sell? - MarketBeat
Hims & Hers stock trims losses following quarterly results - Yahoo Finance
Hims & Hers Health (HIMS) Faces Profitability Concerns Amid Stro - GuruFocus
Hims & Hers Health: Investments Necessary For Long-Term Incremental Growth, Says Bullish Analyst - Benzinga
Hims & Hers Health Sees Mixed Q2 as Gross Margin, FCF Weigh, Morgan Stanley Says - Yahoo Finance
Hims & Hers shares slide as costly weight-loss push squeezes margins - Reuters
Hims & Hers Health, Inc. Stock 12‑Month Price Target Raised to $31.85 - TradingView
Hims & Hers Health Slides on Wider-Than-Expected Q2 Loss - Schaeffer's Investment Research
HIMS Q2 Earnings Call Focuses on AI and Global Expansion - tradingview.com
Why Is Hims & Hers Health Stock Falling Tuesday? - Benzinga
Hims & Hers' Revenue Growth Comes at a Cost - Yahoo Finance
Canaccord reiterates Hims & Hers stock rating after Q2 beat - Investing.com
Hims & Hers Raises Outlook as Cash Flow Weakens - tradingview.com
Hims & Hers Health, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Needham raises Hims and Hers stock price target on GLP-1 growth - Investing.com
Needham & Company LLC Issues Positive Forecast for Hims & Hers Health (NYSE:HIMS) Stock Price - MarketBeat
Hims & Hers Q2 2026 earnings: loss despite revenue beat - qz.com
Hims & Hers Shares Slide as Costly Weight-Loss Push Squeezes MarginsU.S. News - U.S. News - Money
Stocks making the biggest moves premarket: Riot Platforms, Hims & Hers Health, Intel & more - CNBC
Hims & Hers Health, Inc. Stock Analysis: Post-Earnings 6% Drop Outlook - The Cryptonomist
0.79%
5.15%
자본화:
|
볼륨(24시간):